Skip to content
Search

Latest Stories

NPA partners with Charac to accelerate digitisation in community pharmacies

Charac, an NHS-integrated one-stop platform for independent community pharmacies, and the National Pharmacy Association (NPA) have announced their long-term partnership to allow pharmacies to deliver the broad range of services needed to support the public.

The NPA and Charac will collaborate with members of the NPA and beyond to accelerate the necessary digital transition of independent community pharmacies, particularly given their importance to poorer communities and less advantaged individuals at high risk due to potential pharmacy closures.


The partnership is part of the NPA’s efforts to improve the online presence of community pharmacies, including patient application, online booking, website design, and a delivery service. With Charac similarly dedicated to bettering digital interaction with patients, the new joint ecosystem will provide pharmacies with the necessary funding and cutting-edge technology to aid delivery of primary care.

Due to GP shortages and pressures on the NHS, pharmacies are needed more than ever. By 2026, all new pharmacy graduates will qualify as prescribers, and with some 35 medical conditions now not being prescribed medication from a GP, pharmacies have been trumpeted by the government as an alternative option for consultations. However, they need to free up the capacity and means to do this effectively.

One of the biggest opportunities for improving efficiencies is to digitise certain tasks,  to free up more time for patient care.

Charac can help because it is an app designed specifically for community pharmacies, to drive growth, relieve time pressure and increase efficiency. Historically, pharmacies have focused on dispensing medicines, but as the healthcare needs of the population continue to change, pharmacies are providing more holistic care, often involving clinical consultations.

Through Charac, pharmacists are now able to manage repeat prescriptions as well as booking and conducting consultations all in one place and are now able to access patient records, prescriptions, and consultations all in one place. The prescriptions can be delivered directly to a patient’s home due to Charac’s recent £1 million strategic investment from the Royal Mail.

The partnership with the NPA adds Charac’s innovative approach to patient engagement to the association’s business partnership programme, as one of just 52 trusted partners.

Santosh Sahu, Founder of Charac, said: “We are thrilled to announce our long-term partnership with such a well-respected and influential organisation, particularly at a time where the cost-of-living crisis, a looming recession, and a stretched NHS have created a perfect storm for the new health secretary. Greater recognition from the Department of Health for the vital role that pharmacists play in our health ecosystem is essential and Charac stands ready to alleviate these burdens by digitally empowering pharmacists”.

Simon Tebbutt, Director of Membership at the NPA, said: “It is an exciting opportunity to work with a company with the ambition of Charac as one of our trusted partners. Charac presented an attractive solution to enable community pharmacies to modernise their platforms, and we look forward to working towards this shared goal. It is vital that this gap in the market is filled: digital transformation has accelerated immensely over the last couple of years, and has become a necessity in healthcare, reflected in our partnerships with Charac.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less